5-Bromo-2-phenoxypyrimidine

Catalog No. :
ACUVGF514
CAS No. :
257280-25-4
Molecular Formula :
C10H7BrN2O
Molecular Weight :
251.08

IUPAC Name:5-bromo-2-phenoxypyrimidine

5-Bromo-2-phenoxypyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$89.00Login to see priceIn stockIn stock
100g97%$284.00Login to see priceIn stockIn stock
500g97%$1377.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2-phenoxypyrimidine
IUPAC Name5-bromo-2-phenoxypyrimidine
MDL No.MFCD03646346
Molecular FormulaC10H7BrN2O
Molecular Weight251.08
SMILESBrC1=CN=C(N=C1)OC2=CC=CC=C2
InChI KeyZFECRMYYOMVREH-UHFFFAOYSA-N
Synonym5-bromo-2-phenoxypyrimidine | 257280-25-4 | 5-bromo-2-phenoxy-pyrimidine | pyrimidine, 5-bromo-2-phenoxy- | MFCD03646346 | SCHEMBL2313930 | 5-bromanyl-2-phenoxy-pyrimidine | AMY3393 | DTXSID60349083 | ZFECRMYYOMVREH-UHFFFAOYSA-N | AKOS013182306 | AB15669 | 5-Bromo-2-phenoxypyrim
CAS No.257280-25-4
PubChem CID642842

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACUVGF514 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMOFE402 route compound structure diagram
    ACMOFE402183438-24-6 In Stock
  2. Plus
  3. ACPBYR859 route compound structure diagram
    ACPBYR859100-67-4
  4. Then
  5. ACUVGF514 route product structure diagram
    ACUVGF514257280-25-4 In Stock
Inquiry

2. ACUVGF514 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJMSY940 route compound structure diagram
    ACJMSY94032779-36-5 In Stock
  2. Plus
  3. ACPBYR859 route compound structure diagram
    ACPBYR859100-67-4
  4. Then
  5. ACUVGF514 route product structure diagram
    ACUVGF514257280-25-4 In Stock
Inquiry

Comments (0)